Primary care physicians miss hepatitis vaccine targets

Primary care physicians are failing to meet guidelines for hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccination in patients with chronic hepatitis C (HCV) infection, according to US research.

The study also found that family medicine physicians were less knowledgeable about the need for vaccination than their internal medicine counterparts.

"The results of this study suggest that there are substantial gaps in the knowledge and a wide variability in the practice of [internal medicine] and [family medicine] physicians with regard to vaccination of HCV+ patients," say K Herzog (New York University, USA) and colleagues.

The authors received completed questionnaires regarding knowledge about vaccination in HCV+ patients from 557 family care physicians and 652 internal medicine physicians. They noted that internal medicine physicians were significantly more likely to report seeing three or more HCV+ patients per week than family medicine physicians (34.8 vs 29.3%).

Of the family medicine physicians who responded, 62.7% and 65.4% knew that HCV+ patients who test positive for antibodies should receive HAV and HBV vaccination, respectively, compared with 76.5% and 79.6% of internal medicine physicians.

In addition, only 56.4% and 55.7% of family medicine physicians knew that HCV and HIV-co-infected patients required HAV and HBV vaccination, respectively. This compared with 69.9% and 72.9% of internal medicine physicians.

When the physicians were asked about barriers to vaccination, they reported obstacles such as patient refusal, cost, and time constraints. However, Herzog and colleagues also note that some barriers mentioned, such as feeling uncomfortable with vaccination and lacking knowledge of its safety and efficacy, are susceptible to change through educational programs.

The authors explain in the International Journal of Clinical Practice that in the USA, uptake of the recommended vaccination of HCV+ patients has been poor but the role of primary care in this has been little explored. They say that interventions are needed to prevent the morbidity and mortality associated with HAV and HBV infection.

"Among other strategies, physician education and strong practice patterns are needed as well as a healthcare system with wide acknowledgement of the benefits of HAV and HBV vaccination in chronic HCV-infected patients," they conclude.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Thrombotic thrombocytopenic purpura cases after CoronaVac raise concerns over vaccine safety